IDEX BIOMETRICS ASA (IDEX.OL) Fundamental Analysis & Valuation

OSL:IDEX • NO0013536078

Current stock price

9.6 NOK
-0.4 (-4%)
Last:

This IDEX.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IDEX.OL Profitability Analysis

1.1 Basic Checks

  • IDEX had negative earnings in the past year.
  • IDEX had a negative operating cash flow in the past year.
  • In the past 5 years IDEX always reported negative net income.
  • IDEX had a negative operating cash flow in each of the past 5 years.
IDEX.OL Yearly Net Income VS EBIT VS OCF VS FCFIDEX.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -133.36%, IDEX is doing worse than 91.84% of the companies in the same industry.
  • The Return On Equity of IDEX (-413.86%) is worse than 91.84% of its industry peers.
Industry RankSector Rank
ROA -133.36%
ROE -413.86%
ROIC N/A
ROA(3y)-125.99%
ROA(5y)-113.6%
ROE(3y)-408.86%
ROE(5y)-291.18%
ROIC(3y)N/A
ROIC(5y)N/A
IDEX.OL Yearly ROA, ROE, ROICIDEX.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IDEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IDEX.OL Yearly Profit, Operating, Gross MarginsIDEX.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. IDEX.OL Health Analysis

2.1 Basic Checks

  • IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IDEX has more shares outstanding
  • Compared to 5 years ago, IDEX has more shares outstanding
  • IDEX has a better debt/assets ratio than last year.
IDEX.OL Yearly Shares OutstandingIDEX.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
IDEX.OL Yearly Total Debt VS Total AssetsIDEX.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.39 indicates that IDEX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of IDEX (3.39) is better than 65.31% of its industry peers.
  • IDEX has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.42, IDEX is in line with its industry, outperforming 40.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 3.39
ROIC/WACCN/A
WACC8.54%
IDEX.OL Yearly LT Debt VS Equity VS FCFIDEX.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 2.07 indicates that IDEX has no problem at all paying its short term obligations.
  • IDEX has a better Current ratio (2.07) than 71.43% of its industry peers.
  • A Quick Ratio of 0.52 indicates that IDEX may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.52, IDEX is not doing good in the industry: 89.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 0.52
IDEX.OL Yearly Current Assets VS Current LiabilitesIDEX.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. IDEX.OL Growth Analysis

3.1 Past

  • IDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.92%, which is quite impressive.
  • The Revenue for IDEX has decreased by -83.94% in the past year. This is quite bad
  • Measured over the past years, IDEX shows a very negative growth in Revenue. The Revenue has been decreasing by -25.34% on average per year.
EPS 1Y (TTM)80.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.49%
Revenue 1Y (TTM)-83.94%
Revenue growth 3Y-60.4%
Revenue growth 5Y-25.34%
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IDEX.OL Yearly Revenue VS EstimatesIDEX.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IDEX.OL Yearly EPS VS EstimatesIDEX.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2025 0 -50 -100 -150 -200

More info and screens

Find the best growth stocksShow best growing peers

0

4. IDEX.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • IDEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDEX.OL Price Earnings VS Forward Price EarningsIDEX.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDEX.OL Per share dataIDEX.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IDEX.OL Dividend Analysis

5.1 Amount

  • No dividends for IDEX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IDEX.OL Fundamentals: All Metrics, Ratios and Statistics

IDEX BIOMETRICS ASA

OSL:IDEX (4/9/2026, 7:00:00 PM)

9.6

-0.4 (-4%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-03
Earnings (Next)05-21
Inst Owners5.06%
Inst Owner ChangeN/A
Ins Owners33.06%
Ins Owner ChangeN/A
Market Cap624.10M
Revenue(TTM)209.00K
Net Income(TTM)-10.93M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 313.6
P/FCF N/A
P/OCF N/A
P/B 24.83
P/tB 30.58
EV/EBITDA N/A
EPS(TTM)-10.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.48
FCFYN/A
OCF(TTM)-1.48
OCFYN/A
SpS0.03
BVpS0.39
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -133.36%
ROE -413.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-125.99%
ROA(5y)-113.6%
ROE(3y)-408.86%
ROE(5y)-291.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 0.52
Altman-Z 3.39
F-Score3
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-83.94%
Revenue growth 3Y-60.4%
Revenue growth 5Y-25.34%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y43.37%
OCF growth 3YN/A
OCF growth 5YN/A

IDEX BIOMETRICS ASA / IDEX.OL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IDEX BIOMETRICS ASA (IDEX.OL) stock?

ChartMill assigns a fundamental rating of 1 / 10 to IDEX.OL.


What is the valuation status for IDEX stock?

ChartMill assigns a valuation rating of 0 / 10 to IDEX BIOMETRICS ASA (IDEX.OL). This can be considered as Overvalued.


What is the profitability of IDEX stock?

IDEX BIOMETRICS ASA (IDEX.OL) has a profitability rating of 0 / 10.


How financially healthy is IDEX BIOMETRICS ASA?

The financial health rating of IDEX BIOMETRICS ASA (IDEX.OL) is 4 / 10.